Thomas E. Wagner

9.7k citations

198 papers · 7.9k indexed · 2 hit papers · h-index 42

Impact in

Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
Aging top 1%

Papers in

Genetics 74
- Animal Genetics and Reproduction 53
- Virus-based gene therapy research 29
Molecular Biology 124
- DNA and Nucleic Acid Chemistry 25
- CRISPR and Genetic Engineering 19
- RNA Interference and Gene Delivery 18
- RNA and protein synthesis mechanisms 14

Co-authors: Stephen F. Vatner Xianzhong Yu John J. Kopchick Eric Holle Junichi Sadoshima David C. Wight Andrzej Bartke Peiyong Zhai
Journals: Biochemistry (9 papers)Endocrinology (9 papers)Circulation Research (9 papers)International Journal of Oncology (8 papers)Proceedings of the National Academy of Sciences (8 papers)
Partner nations: United States Germany Japan

In The Last Decade

Thomas E. Wagner

192 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart 2007 · 939 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Circulation Research
1997 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Thomas E. Wagner

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Wagner more than expected).

Fields of papers citing papers by Thomas E. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Wagner. The network helps show where Thomas E. Wagner may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas E. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas E. Wagner Line = papers co-authored together Thomas E. Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation International Journal of Oncology ·Lining Zhu, Zhihui Zhao, Yanzhang Wei, William R. Marcotte, Thomas E. Wagner, Xianzhong Yu	2012	4
2	In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors Cancer Gene Therapy ·Hari Kotturi, J Li, Melissa Branham-O’Connor, Xianzhong Yu, Thomas E. Wagner, Yanzhang Wei	2009	5
3	Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors Molecular Pharmacology ·Tobias Eltze, Rainer Boer, Thomas E. Wagner, Steffen Weinbrenner, Michelle C. McDonald, Christoph Thiemermann, Alexander Bürkle, Thomas Klein	2008	57
4	Glycogen Synthase Kinase-3α Reduces Cardiac Growth and Pressure Overload-induced Cardiac Hypertrophy by Inhibition of Extracellular Signal-regulated Kinases Journal of Biological Chemistry ·Peiyong Zhai, Shumin Gao, Eric Holle, Xianzhong Yu, Atsuko Yatani, Thomas E. Wagner, Junichi Sadoshima	2007	55
5	An Angiotensin II Type 1 Receptor Mutant Lacking Epidermal Growth Factor Receptor Transactivation Does Not Induce Angiotensin II–Mediated Cardiac Hypertrophy Circulation Research ·Peiyong Zhai, Jonathan Galeotti, Jing Liu, Eric Holle, Xianzhong Yu, Thomas E. Wagner, Junichi Sadoshima	2006	79
6	Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy Journal of Clinical Investigation ·Mitsutaka Yamamoto, Guiping Yang, Chull Hong, Jing Liu, Eric Holle, Xianzhong Yu, Thomas E. Wagner, Stephen F. Vatner, Junichi Sadoshima	2003	208
7	Pentopyranosyl Oligonucleotide Systems Helvetica Chimica Acta ·Thomas E. Wagner, Hoan K. Huyuh, Ramanarayanan Krishnamurthy, Albert Eschenmoser	2002	5
8	Cytoplasmic Expression of Ribozyme In Zebrafish Using a T7 Autogene System Current Issues in Molecular Biology ·Kat Walker, Yuran Xie, Yunsheng Li, Qun Zhu, Wei Xu, Thomas E. Wagner, Xiaozhuo Chen	2001	3
9	Long‐term Combination of Interferon Alfa‐2b and Ribavirin for Hepatitis C Recurrence in Liver Transplant Patients American Journal of Transplantation ·A. Kornberg, Merten Hommann, Andrea Tannapfel, Thomas E. Wagner, T. Grube, U. Schotte, Rigo Voigt, Johannes Scheele	2001	29
10	Differential regulation of inotropy and lusitropy in overexpressed Gsα myocytes through cAMP and Ca2+ channel pathways Journal of Clinical Investigation ·Song‐Jung Kim, Atsuko Yatani, Dorothy E. Vatner, Satoshi Yamamoto, Yoshihiro Ishikawa, Thomas E. Wagner, Richard P. Shannon, Young-Kwon Kim, Gen Takagi, Kuniya Asai, C J Homcy, Stephen F. Vatner	1999	29
11	Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. Journal of Clinical Investigation ·Dorothy E. Vatner, Kuniya Asai, Mitsunori Iwase, Yoshihiro Ishikawa, Thomas E. Wagner, Richard P. Shannon, C J Homcy, Stephen F. Vatner	1998	41
12	Differential regulation of G protein α‐subunit GTPase activity by peptides derived from the third cytoplasmic loop of the α₂‐adrenergic receptor FEBS Letters ·Thomas E. Wagner, C. Oppi, Glauco P. Tocchini Valentini	1995	5
13	Overexpression of Gs alpha protein in the hearts of transgenic mice. Journal of Clinical Investigation ·Christophe Gaudin, Yoshihiro Ishikawa, David C. Wight, Vijak Mahdavi, B Nadal-Ginard, Thomas E. Wagner, Dorothy E. Vatner, C J Homcy	1995	116
14	Testosterone Feedback on Gonadotropin Secretion and Gene Expression in Transgenic Mice Expressing Human Growth Hormone Gene Journal of Andrology ·Kechun Tang, Andrzej Bartke, Catherine S. Gardiner, Thomas E. Wagner, JEUNG S. YUN‡	1994	5
15	Effects of Heterologous Growth Hormones on Hypothalamic and Pituitary Function in Transgenic Mice Neuroendocrinology ·Richard W. Steger, Andrzej Bartke, T. A. Parkening, Thomas J. Collins, F. C. Buonomo, Kechun Tang, Thomas E. Wagner, Jun Seop Yun	1991	40
16	Effect of Immunoneutralization of Neuropeptide Y on Gonadotropin and Prolactin Secretion in Normal Mice and in Transgenic Mice Bearing Bovine Growth Hormone Gene* Endocrinology ·Pradip Ghosh, Luciano Debéljuk, Thomas E. Wagner, Andrzej Bartke	1991	16
17	Elevated Corticosterone Levels in Transgenic Mice Expressing Human or Bovine Growth Hormone Genes Neuroendocrinology ·Marcelo Cecim, Pradip Ghosh, Ana I. Esquifino, Timothy Began, Thomas E. Wagner, Junes S. Yun, Andrzej Bartke	1991	39
18	Production of transgenic pigs harbouring a rat phosphoenolpyruvate carboxykinase-bovine growth hormone fusion gene. PubMed ·M. Wieghart, J. L. Hoover, M.M. McGrane, R W Hanson, Fritz Rottman, S. H. Holtzman, Thomas E. Wagner, Carl A. Pinkert	1990	29
19	A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocysts Theriogenology ·R.M. Strojek, Michael A. Reed, J. L. Hoover, Thomas E. Wagner	1990	79
20	A Development Program for Middle Managers. Thomas E. Wagner	1974	0

About Thomas E. Wagner

Thomas E. Wagner is a scholar working on Genetics, Molecular Biology, Immunology, Biotechnology and Endocrinology, Diabetes and Metabolism, having authored 198 papers that have together received 7.9k indexed citations. Recurring topics across this work include Animal Genetics and Reproduction (53 papers), Virus-based gene therapy research (29 papers), Immunotherapy and Immune Responses (26 papers), DNA and Nucleic Acid Chemistry (25 papers), CRISPR and Genetic Engineering (19 papers), Growth Hormone and Insulin-like Growth Factors (19 papers), RNA Interference and Gene Delivery (18 papers) and RNA and protein synthesis mechanisms (14 papers). The work is most often cited by research in Geriatrics and Gerontology (549 citations), Aging (241 citations), Endocrinology, Diabetes and Metabolism (1.6k citations), Molecular Biology (4.4k citations) and Genetics (1.6k citations). Thomas E. Wagner has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Stephen F. Vatner, Xianzhong Yu, John J. Kopchick, Eric Holle, Junichi Sadoshima, David C. Wight, Andrzej Bartke, Peiyong Zhai, Shumin Gao and Bin Tian. Their work appears in journals such as Biochemistry, Endocrinology, Circulation Research, International Journal of Oncology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact